Innovative Antiviral Medications

OmnivirUSA believes that the development of broad-spectrum medications for viral diseases is an indispensable strategy for human survival and progress. OmnivirUSA has been intensely engaged in this field of research for over eight years, and believes this strategy is manifestly more productive and cost-effective than the one-virus-at-a-time typical research policies of most pharmaceutical companies and historically, governments.

5 U.S. Patents Awarded

Five U.S. patents relating to broad-spectrum antivirals have been awarded to the President of OmnivirUSA over the last few years, and additional patent applications are pending.